Mark Pegram, MD, is the Suzy Yuan-Huey Hung Endowed Professor of Medical Oncology at the Stanford Cancer Institute. He currently serves as the Associate Director of Clinical Research at the Stanford Comprehensive Cancer Institute (SCCI). He also serves as the Associate Dean for Clinical Research Quality at the Stanford University School of Medicine and is the Medical Director of the Stanford Clinical Translational Research Unit – a unit specializing in first-in-human phase I clinical trials. In this video, he speaks about the Miami Breast 2022 Discussion – New Frontiers in Breast Cancer: Targeted Therapy, Immunotherapy, and Combinations.
Podcast Mark Pegram, MD @Stanford @StanfordCancer #MiamiBreast22 #Breast22 New Frontiers in Breast Cancer
By Editor